Effect of Pertussis Toxin and Herbimycin A on Proteinase-Activated Receptor 2-Mediated Cyclooxygenase 2 Expression in Helicobacter pylori-Infected Gastric Epithelial AGS Cells by Seo, Ji Hye et al.
Yonsei Med J   http://www.eymj.org   Volume 52   Number 3   May 2011 522
Brief Communication
DOI 10.3349/ymj.2011.52.3.522
pISSN: 0513-5796, eISSN: 1976-2437          Yonsei Med J 52(3):522-526, 2011
Effect of Pertussis Toxin and Herbimycin A on Proteinase-
Activated Receptor 2-Mediated Cyclooxygenase 2 Expression  
in Helicobacter pylori-Infected Gastric Epithelial AGS Cells 
Ji Hye Seo,
1 Jeong Yeon Seo,
2 Hae-Yun Chung,
3 and Hyeyoung Kim
4
1Department of Pharmacology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul;
2Department of Physiology, Tissue Injury Defense Research Center, College of Medicine, Ewha Womans University, Seoul;
3Institute of Food and Nutritional Science, College of Human Ecology, Yonsei University, Seoul;
4Department of Food and Nutrition, Brain Korea 21 Project, College of Human Ecology, Yonsei University, Seoul, Korea.
Received: August 17, 2009
Revised: October 9, 2009
Accepted: October 15, 2009
Corresponding author: Dr. Hyeyoung Kim,
Department of Food and Nutrition, 
College of Human Ecology, Yonsei University, 
50 Yeonse-ro, Seodaemun-gu, 
Seoul 120-749, Korea.
Tel: 82-2-2123-3125, Fax: 82-2-364-5781
E-mail: kim626@yonsei.ac.kr
∙ The authors have no financial conflicts of 
interest.
© Copyright:
Yonsei University College of Medicine 2011
This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/ 
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Helicobacter pylori (H. pylori) is an important risk factor for chronic gastritis, pep-
tic ulcer, and gastric cancer. Proteinase-activated receptor 2 (PAR2), subgroup of 
G-protein coupled receptor family, is highly expressed in gastric cancer, and 
chronic expression of cyclooxygenase-2 (COX-2) plays an important role in H. 
pylori-associated gastric carcinogenesis and inflammation. We previously demon-
strated that H. pylori induced the expression of PAR2 and COX-2 in gastric epi-
thelial cells. Present study aims to investigate whether COX-2 expression induced 
by H. pylori in Korean isolates is mediated by PAR2 via activation of Gi protein 
and Src kinase in gastric epithelial AGS cells. Results showed that H. pylori-in-
duced COX-2 expression was inhibited in the cells transfected with antisense oli-
gonucleotide for PAR2 or treated with Gi protein blocker pertussis toxin, Src ki-
nase inhibitor herbimycin A and soybean trypsin inbitor, indicating that COX-2 
expression is mediated by PAR2 through activation of Gi protein and Src kinase in 
gastric epithelial cells infected with H. pylori in Korean isolates. Thus, targeting 
the activation of PAR2 may be beneficial for prevention or treatment of gastric in-
flammation and carcinogenesis associated with H. pylori infection.
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H. pylori-associated acute and chronic antral inflammation has been associated 
with the expression of cyclooxygenase-2 (COX-2) in gastric epithelial cells,1 
which is strongly correlated with the extent of chronic inflammatory cell infiltrate.2 
Chronic expression of COX-2 is related to H. pylori-associated gastric carcinogen-
esis in addition to propagation of gastric inflammation since prostaglandins pro-
duced via COX-2 are reported to contribute to inflammation3 and carcinogenesis.4 
Our previous study demonstrated that oxidant-sensitive transcription factor NF-κB 
mediates COX-2 expression, which may be related to cell proliferation in gastric 
epithelial cells.5 H. pylori-induced activation of NF-κB mediates the expression of PAR2-Mediated COX-2 Expression
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In the present study, we investigated whether H. pylori-
induced COX-2 expression is mediated by PAR2 via activa-
tion of Gi protein and Src kinase in gastric epithelial AGS 
cells. Thus, the cells were transfected with sense oligonu-
cleotide (S ODN) and antisense oligonucleotide (AS ODN) 
for PAR2 and cultured in the presence of H. pylori. In other 
sets of experiments, the cells were treated with Gi protein 
blocker pertussis toxin, Src kinase inhibitor herbimycin A 
or soybean trypsin inhibitor for 1 hour and cultured in the 
presence of H. pylori. Subsequently, mRNA and protein ex-
pression of COX-2 were determined by RT-PCR analysis 
and Western blot analysis, respectively. Pertussis toxin in-
hibits Gi protein by coupling the inhibitory receptors to the 
adenylate cyclase system.21 Herbimycin A is known to be an 
irreversible inhibitor of Src kinase.22
We used HP99 which was isolated from gastric antral mu-
cosa of Korean patients with gastric and duodenal ulcer, and 
identified it as cagA+, vacA s1b, m2, iceA1 H. pylori strain.23 
H. pylori was added to human gastric epithelial AGS cells 
(ATCC CRL 1739, American Type Culture Collection, 
Manassas, Virginia, USA) at a bacterium/cell ratio of 100 : 1 
in a 3 mL volume. The cells were transfected with S ODN 
and AS ODN for PAR2 for 16 hours and cultured in the pres-
ence of H. pylori. In other sets of experiments, the cells were 
treated with Gi protein blocker pertussis toxin (400 ng/mL), 
Src kinase inhibitor herbimycin A (10 µM), or soybean tryp-
sin inhibitor (1, 2, 5 nM) for 1 hours and cultured in the pres-
ence of H. pylori. mRNA and protein expression of COX-2 
were determined by reverse transcription-polymerase chain 
reaction (RT-PCR) analysis (at 12 hours) and Western blot 
analysis (at 24 hours), respectively. For ODN preparation, 
single-stranded ODNs were prepared commercially (GIB-
CO-BRL, New York, USA). ODNs were phosphorothioate-
modified to reduce intracellular nuclease digestion. AS ODN 
and S ODN target the ATG start codon of the PAR2 mRNA. 
The sequence of PAR-2 AS ODN was 5’-TCCG-
CATCCTCCTGGAA-3’, and that of PAR2 S ODN was 
5’-TTCCAGGAGGATGC GGA-3’. For RT-PCR analysis, 
the primers used were: PAR2, forward 5’-GATGGCA-
CATCCCACGTC-3’, reverse 5’-GGCATGTATGTGATAG-
GC-3’, giving a 288 bp PCR product; COX-2, forward 
5’-TTCAAATGAGATTGTGGGAAAATTGCT-3’, reverse 
5’-AGATCATCTCTGCCTGAGTATCTT- 3’, giving a 296 
bp PCR produc; β-actin, forward 5’-ACCAACTGGGAC-
GACATGGAG-3’, reverse 5’-GTGAGGATCTTCATGAG-
GTAGTC-3’, giving a 354 bp PCR product. The PCR prod-
ucts were amplified and visualized by UV transilumination.23 
several genes involved in inflammation, such as IL-86 and 
adhesion molecules intergrin α5, in gastric epithelial AGS 
cells.7 Proteinase-activated receptor 2 (PAR2) regulates cell 
proliferation and enhances COX-2 expression in human 
pancreatic cancer cells8 and integrin expression in H. pylo-
ri-infected gastric epithelial cells.9
Proteinase-activated receptors (PARs) are G protein-cou-
pled receptors that are activated by the cleavage of their N-
terminal domains by proteases.10,11 Proteinase-activated re-
ceptor 2 (PAR2) activation induces G protein-mediated 
signal transduction, generation of inositol triphosphate, mo-
bilization of intracellular calcium, the activation of mito-
gen-activated protein kinase, cell growth, and the release of 
cytokines (IL-6, IL-8) and prostaglandins.12,13 PAR2 is acti-
vated by multiple trypsin-like serine proteases including 
trypsin and tryptase.13 Inflammatory cytokines (interleukin-
1α, tumor necrosis factor-α) increase mRNA expression of 
PAR2.14 Invasive breast and pancreatic cancer cells express 
high levels of PAR2 compared with normal cells.15 These 
studies show the positive relationship between PAR2 ex-
pression and carcinogenesis. Previously, we demonstrated 
that H. pylori induced the expression and activation of PAR2 
by stimulating the expression of trypsinogens and trypsin in 
gastric epithelial AGS cells.9 In addition, inhibition of PAR2 
activation by a soyben trypsin inhibitor (SBTI) suppressed H. 
pylori-induced expression of integrins in gastric epithelial 
cells.9 Therefore, PAR2 seems to play an important role in H. 
pylori-associated gastric inflammation and/or carcinogenesis 
by mediating the induction of inflammatory and carcinogenic 
genes, including COX-2, in gastric epithelial cells. 
In addition, the genetic differences of H. pylori isolates 
play a role in the clinical outcome of the infection, particu-
larly H. pylori-virulence associated genes such as vacA, 
cagA, and iceA genes.16 Infection by cagA strain is more 
likely to result in peptic ulceration, atrophic gastritis, and 
gastric carcinoma.17,18 Presence of cagA or vacA in H. pylo-
ri strain showed different expression of genes as compared 
to cagA negative or vacA negative H. pylori in gastric epi-
thelial AGS cells.19 The studies suggest that the presence of 
virulence factors (vacA, cagA, and iceA) and isotypes of each 
virulence factor (vacA s1b m2, vacA s1c m1, iceA1, iceA2 
etc.) in H. pylori strain are important to determine disease 
incidence related to H. pylori infection. Since the predomi-
nant genotype of H. pylori in Korea has been reported to be 
cagA positive and vacA positive genotype,20 H. pylori in 
Korean isolates may be used to determine the pathogenic 
mechanism of H. pylori-induced gastric diseases in Korea.Ji Hye Seo, et al.
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fection efficiency of ODN was determined by observing 
mRNA and protein levels of PAR2 in the cells transfected 
(Fig. 1A). H. pylori-induced PAR2 expression was inhibit-
ed in the cells transfected with AS ODN, but not changed 
in those transfected with S ODN. H. pylori-induced expres-
sion of COX-2 was similarly inhibited in the cells transfect-
ed with AS ODN compared to those in the cells transfected 
with S ODN (Fig. 1B). Since protein level and the activity 
of trypsin increased in H. pylori-infected AGS cells,9 trypsin 
may activate PAR2 in AGS cells. Previously, we showed the 
increase of intracellular Ca mobilization by PAR2 activa-
tion in H. pylori-infected AGS cells,25 which was inhibited 
by SBTI (data not shown), demonstrating that SBTI in AGS 
cells suppresses PAR activation induced by H. pylori. Using 
SBTI, we determined whether SBTI suppresses H. pylori-
induced expression of COX-2 in AGS cells. As seen in Fig. 
2A, H. pylori-induced expression of COX-2 was inhibited 
dose-dependently by SBTI. G protein coupled receptor 
(GPRC) signalings have been shown to be inhibited by per-
tussis toxin, which inactivates ADP-ribosylation of α sub-
For Western blot analysis, the proteins were detected with 
polyclonal antibodies for PAR2 (Catalog # SC-13504) and 
COX-2 (Catalog # SC-19999), perchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA), at 1 : 1000 dilation 
and the immunoreactive proteins were visualized by en-
hanced chemiluminescence.24
Since mRNA and protein expressions of COX-2 were evi-
dent at 12 hours and 24 hours in our previous study,24 in the 
following experiments using transfection with S ODN and 
AS ODN for PAR2 or treatment with Gi protein blocker per-
tussis toxin, Src kinase inhibitor herbimycin A and SBTI, re-
spectively, the time points of 12 hours and 24 hours for 
mRNA and protein expressions of COX-2, respectively, 
were used. β-Actin (for mRNA) and actin (for protein) were 
constitutively expressed in the cells and not changed with 
culture period.
To determine direct involvement of PAR2 in the expres-
sion of COX-2, the cells were transfected with PAR2 AS 
ODN or S ODN and cultured in the presence of H. pylori 
for 12 hours (mRNA) or 24 hours (protein) (Fig. 1). Trans-
Fig. 2. H. pylori-induced expression of COX-2 is inhibited in AGS cells treat-
ed with soybean trypsin inhibitor (SBTI), pertussis toxin and herbimycin A. 
AGS cells in 6-well culture plates were treated with SBTI (1, 2, 5 nM) (A), or 
pertussis toxin (400 ng/mL) or herbimycin A (10 µM) (B) for 1 h and cultured 
in the presence of H. pylori at a bacterium/cell ratio of 100 : 1 for 12 h (for 
mRNA) or 24 h (for protein). COX-2 mRNA expression levels were deter-
mined by RT-PCR and at protein level by Western blotting. COX-2, cycloox-
ygenase-2.
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Fig. 1. H. pylori-induced expressions of PAR2 and COX-2 are inhibited in 
AGS cells transfected with PAR2 AS ODN. AGS cells were seeded in 6-well 
culture plates at 5×10
5 cells per well transfected with S or AS ODNs for 
PAR-2 for 16 h. The bacterial cells were added to the cultured cells at a 
bacterium/cell ratio of 100 : 1 for 12 h (for mRNA) or 24 h (for protein). The 
expressions of mRNA and protein for PAR2 (A) and COX-2 (B) were deter-
mined by RT-PCR and Western blotting, respectively. PAR2, proteinase-ac-
tivated receptor 2; COX-2, cyclooxygenase-2.
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